Effects of cigarette smoking and carbon monoxide on nicotine and cotinine metabolism

被引:57
作者
Benowitz, NL
Jacob, P
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Med Ctr,Med Serv, Div Clin Pharmacol & Expt Therapeut, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA
关键词
D O I
10.1067/mcp.2000.107086
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To examine the effects of cigarette smoking on the disposition kinetics of nicotine and cotinine, to determine the effects of cigarette smoking on pathways of nicotine and cotinine metabolism, and to test the hypothesis that carbon monoxide inhibits the metabolism of nicotine. Study design: Twelve cigarette smokers were studied in three treatment conditions, each lasting 7 days, during which they smoked cigarettes, breathed carbon monoxide to achieve carboxyhemoglobin levels similar to cigarette smoking, or breathed air. In each treatment condition, subjects received a combined infusion of deuterium-labeled nicotine (d(2)) and cotinine (d(4)), with measurement of disposition kinetics and urine metabolite profile. Results: Cigarette smoking significantly inhibited the metabolism of nicotine but had no effect on cotinine metabolism. Cigarette smoking markedly induced the O-glucuronidation of trans-3'-hydroxycotinine but had no effect on the N-glucuronidation of nicotine or cotinine, Carbon monoxide had no effect on nicotine or cotinine kinetics or metabolic profile. Conclusions: This study confirms previous observations that cigarette smoking inhibits nicotine metabolism but disproves the hypothesis that this effect is due to carbon monoxide, Induction of glucuronidation must be considered in understanding the effects of cigarette smoking on drug metabolism.
引用
收藏
页码:653 / 659
页数:7
相关论文
共 20 条
[1]   METABOLISM OF NICOTINE TO COTININE STUDIED BY A DUAL STABLE-ISOTOPE METHOD [J].
BENOWITZ, NL ;
JACOB, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (05) :483-493
[2]   NICOTINE AND COTININE ELIMINATION PHARMACOKINETICS IN SMOKERS AND NONSMOKERS [J].
BENOWITZ, NL ;
JACOB, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (03) :316-323
[3]  
BENOWITZ NL, 1994, J PHARMACOL EXP THER, V268, P296
[4]  
BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318
[5]  
BENOWITZ NL, 1999, NEURONAL NICOTINIC R, P213
[6]   INDUCTION OF CYTOCHROME P-448 ISOENZYMES AND RELATED GLUCURONYLTRANSFERASES IN THE HUMAN-LIVER BY CIGARETTE-SMOKING [J].
FLEISCHMANN, R ;
REMMER, H ;
STARZ, U .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (04) :475-480
[7]   EFFECT OF CIGARETTE-SMOKING ON MEXILETINE KINETICS [J].
GRECHBELANGER, O ;
GILBERT, M ;
TURGEON, J ;
LEBLANC, PP .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (06) :638-643
[8]   DETERMINATION OF THE NICOTINE METABOLITE TRANS-3'-HYDROXYCOTININE IN URINE OF SMOKERS USING GAS-CHROMATOGRAPHY WITH NITROGEN-SELECTIVE DETECTION OR SELECTED ION MONITORING [J].
JACOB, P ;
SHULGIN, AT ;
YU, L ;
BENOWITZ, NL .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 583 (02) :145-154
[9]   SELECTED ION MONITORING METHOD FOR DETERMINATION OF NICOTINE, COTININE AND DEUTERIUM-LABELED ANALOGS - ABSENCE OF AN ISOTOPE EFFECT IN THE CLEARANCE OF (S)-NICOTINE-3',3'-D2 IN HUMANS [J].
JACOB, P ;
YU, L ;
WILSON, M ;
BENOWITZ, NL .
BIOLOGICAL MASS SPECTROMETRY, 1991, 20 (05) :247-252
[10]   INFLUENCE OF TOBACCO ABSTINENCE ON THE DISPOSITION KINETICS AND EFFECTS OF NICOTINE [J].
LEE, BL ;
BENOWITZ, NL ;
JACOB, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (04) :474-479